Ensystex to test BioProspect's termiticide
The US pest control company, Ensystex (Fayetteville, North Carolina), has agreed to conduct efficacy testing on Australian firm BioProspect’s (Brisbane, Queensland) eremophilone oil-based termiticide, Termilone, in Australia. It will carry out a three-month colony control trial and a two-year residual efficacy trial as part of the product registration process. BioProspect hopes to receive Australian approval for the active ingredient in early 2010. BioProspect and Ensystex entered into an initial product evaluation agreement for Termilone in January 2009 ( Agrow No 560, p 3).